https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Thus, CD1d expression represents a novel target for NKT cell-based immunotherapy for glioblastoma patients.In eukaryotes, DNA damage tolerance (DDT) is determined by two repair pathways, homologous repair recombination (HRR) and a pathway controlled by the RAD6-epistatic group of genes. Monoubiquitylation of PCNA mediates an error-prone pathway, whereas polyubiquitylation stimulates an error-free pathway. The error-free pathway involves components of recombination repair; however, the factors that act in this pathway remain largely un
Like
Comment
Share
